This week in our #GetToKnowBostonBio series, we highlight Bridget Walton, Vice President & Principal Consultant and a key member of our world-class regulatory consulting practice in CNS. Bridget is a proven regulatory leader with 25 years of development experience with a focus on neurology and psychiatry products. Her expertise spans all stages of product development, and she has led the preparation and defense of several successful global marketing applications including the original NDA for Latuda® (lurasidone).
Bridget is an accomplished regulatory strategist and former head of regulatory affairs, and is passionate about building, mentoring, and leading teams of regulatory professionals to deliver company regulatory objectives.
To learn more about how Bridget and the other consultants of Boston Biodevelopment can help you achieve your company’s regulatory goals, visit us at www.bostonbiodevelopment.com.
